Skip to main content

Home/ Dr. Goodyear/ Group items tagged HMG-CoQ reductase inhibitors

Rss Feed Group items tagged

Filter: All | Bookmarks | Topics Simple Middle
Nathan Goodyear

Coenzyme Q10 in neuromuscular and neurodegenerativ... [Curr Drug Targets. 2010] - PubMe... - 0 views

www.ncbi.nlm.nih.gov/...20017723

CoQ10 Alzheimer's Parkinson's ALS Dementia Neurodegenerative disease

shared by Nathan Goodyear on 07 Feb 11 - No Cached
  • a deficit in CoQ10 status has been determined in a number of neuromuscular and neurodegenerative disorders
  • A secondary loss of CoQ10 status following HMG-Coa reductase inhibitor (statins) treatment has be implicated in the pathophysiology of the myotoxicity associated with this pharmacotherapy
  • Nathan Goodyear on 07 Feb 11
     
    CoQ10 contributes to neurodegenerative disease, Parkinson's, Alzheimer's, ALS..., in some
Nathan Goodyear

The clinical use of HMG CoA-reductase inhibitors a... [Biofactors. 2003] - PubMed result - 0 views

www.ncbi.nlm.nih.gov/...14695925

statin drugs CoQ10 heart function crestor lipitor

shared by Nathan Goodyear on 16 Nov 10 - No Cached
  • Nathan Goodyear on 16 Nov 10
     
    Statin drugs (lipitor, crestor...) deplete CoQ10 which reduces heart Ejection Fraction
Nathan Goodyear

Use of statins is associated with lower serum total and non-SHBG-bound testosterone lev... - 0 views

www.ncbi.nlm.nih.gov/...26034077

Statin statin therapy statins Testosterone low T low Testosterone free Testosterone HMG-CoQ reductase inhibitors

shared by Nathan Goodyear on 03 Jun 15 - No Cached
  • Nathan Goodyear on 03 Jun 15
     
    Statin use associated with lower total Testosterone and "non-SHBG bound Testosterone" (i.e. free testosterone) in men.  The higher the dose, the lower the trend in Testosterone.  The study found decreased testosterone could occur as soon as 1 month.
1 - 3 of 3
Showing 20▼ items per page